Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
A phase II trial of continuous, oral low-dose estramustineand etoposide chemotherapy in the treatment ofsymptomatic hormone-refractory prostate cancer (HRCP) Proceeding/Conference:International Journal of Urology | 2004 |